213 related articles for article (PubMed ID: 35854080)
1. Xanthine oxidoreductase activity is correlated with hepatic steatosis.
Yagi C; Kusunoki Y; Tsunoda T; Murase T; Nakamura T; Osugi K; Ohigashi M; Morimoto A; Miyoshi A; Kakutani-Hatayama M; Kosaka-Hamamoto K; Kadoya M; Konishi K; Shoji T; Koyama H
Sci Rep; 2022 Jul; 12(1):12282. PubMed ID: 35854080
[TBL] [Abstract][Full Text] [Related]
2. Xanthine oxidoreductase activity is correlated with insulin resistance and subclinical inflammation in young humans.
Washio KW; Kusunoki Y; Murase T; Nakamura T; Osugi K; Ohigashi M; Sukenaga T; Ochi F; Matsuo T; Katsuno T; Moriwaki Y; Yamamoto T; Namba M; Koyama H
Metabolism; 2017 May; 70():51-56. PubMed ID: 28403945
[TBL] [Abstract][Full Text] [Related]
3. Independent association of plasma xanthine oxidoreductase activity with serum uric acid level based on stable isotope-labeled xanthine and liquid chromatography/triple quadrupole mass spectrometry: MedCity21 health examination registry.
Kurajoh M; Fukumoto S; Emoto M; Murase T; Nakamura T; Ishihara T; Go H; Yamamoto K; Nakatani S; Tsuda A; Yamada S; Morioka T; Mori K; Imanishi Y; Inaba M
Clin Chem Lab Med; 2020 Apr; 58(5):780-786. PubMed ID: 31085741
[TBL] [Abstract][Full Text] [Related]
4. A highly sensitive assay for xanthine oxidoreductase activity using a combination of [(13) C2 ,(15) N2 ]xanthine and liquid chromatography/triple quadrupole mass spectrometry.
Murase T; Oka M; Nampei M; Miyachi A; Nakamura T
J Labelled Comp Radiopharm; 2016 May; 59(5):214-20. PubMed ID: 27006202
[TBL] [Abstract][Full Text] [Related]
5. Xanthine oxidoreductase activity assay in tissues using stable isotope-labeled substrate and liquid chromatography high-resolution mass spectrometry.
Murase T; Nampei M; Oka M; Ashizawa N; Matsumoto K; Miyachi A; Nakamura T
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jan; 1008():189-197. PubMed ID: 26673227
[TBL] [Abstract][Full Text] [Related]
6. Plasma Xanthine Oxidoreductase Activity as a Novel Biomarker of Metabolic Disorders in a General Population.
Furuhashi M; Matsumoto M; Tanaka M; Moniwa N; Murase T; Nakamura T; Ohnishi H; Saitoh S; Shimamoto K; Miura T
Circ J; 2018 Jun; 82(7):1892-1899. PubMed ID: 29643318
[TBL] [Abstract][Full Text] [Related]
7. Xanthine oxidoreductase activity in marathon runners: potential implications for marathon-induced acute kidney injury.
Kosaki K; Kumamoto S; Tokinoya K; Yoshida Y; Sugaya T; Murase T; Akari S; Nakamura T; Nabekura Y; Takekoshi K; Maeda S
J Appl Physiol (1985); 2022 Jul; 133(1):1-10. PubMed ID: 35608201
[TBL] [Abstract][Full Text] [Related]
8. A highly sensitive assay of human plasma xanthine oxidoreductase activity using stable isotope-labeled xanthine and LC/TQMS.
Murase T; Nampei M; Oka M; Miyachi A; Nakamura T
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Dec; 1039():51-58. PubMed ID: 27816314
[TBL] [Abstract][Full Text] [Related]
9. Annual change in plasma xanthine oxidoreductase activity is associated with changes in liver enzymes and body weight.
Furuhashi M; Koyama M; Matsumoto M; Murase T; Nakamura T; Higashiura Y; Tanaka M; Moniwa N; Ohnishi H; Saitoh S; Shimamoto K; Miura T
Endocr J; 2019 Sep; 66(9):777-786. PubMed ID: 31130575
[TBL] [Abstract][Full Text] [Related]
10. Differential regulation of hypoxanthine and xanthine by obesity in a general population.
Furuhashi M; Koyama M; Higashiura Y; Murase T; Nakamura T; Matsumoto M; Sakai A; Ohnishi H; Tanaka M; Saitoh S; Moniwa N; Shimamoto K; Miura T
J Diabetes Investig; 2020 Jul; 11(4):878-887. PubMed ID: 31916414
[TBL] [Abstract][Full Text] [Related]
11. Xanthine oxidoreductase activity is associated with serum uric acid and glycemic control in hemodialysis patients.
Nakatani A; Nakatani S; Ishimura E; Murase T; Nakamura T; Sakura M; Tateishi Y; Tsuda A; Kurajoh M; Mori K; Emoto M; Inaba M
Sci Rep; 2017 Nov; 7(1):15416. PubMed ID: 29133805
[TBL] [Abstract][Full Text] [Related]
12. Unexpected high plasma xanthine oxidoreductase activity in female subjects with low levels of uric acid.
Furuhashi M; Mori K; Tanaka M; Maeda T; Matsumoto M; Murase T; Nakamura T; Koyama M; Moniwa N; Ohnishi H; Saitoh S; Shimamoto K; Miura T
Endocr J; 2018 Nov; 65(11):1083-1092. PubMed ID: 30068899
[TBL] [Abstract][Full Text] [Related]
13. Independent links between plasma xanthine oxidoreductase activity and levels of adipokines.
Furuhashi M; Matsumoto M; Murase T; Nakamura T; Higashiura Y; Koyama M; Tanaka M; Moniwa N; Ohnishi H; Saitoh S; Shimamoto K; Miura T
J Diabetes Investig; 2019 Jul; 10(4):1059-1067. PubMed ID: 30516339
[TBL] [Abstract][Full Text] [Related]
14. New insights into purine metabolism in metabolic diseases: role of xanthine oxidoreductase activity.
Furuhashi M
Am J Physiol Endocrinol Metab; 2020 Nov; 319(5):E827-E834. PubMed ID: 32893671
[TBL] [Abstract][Full Text] [Related]
15. Relationship between plasma xanthine oxidoreductase activity and left ventricular ejection fraction and hypertrophy among cardiac patients.
Fujimura Y; Yamauchi Y; Murase T; Nakamura T; Fujita SI; Fujisaka T; Ito T; Sohmiya K; Hoshiga M; Ishizaka N
PLoS One; 2017; 12(8):e0182699. PubMed ID: 28797123
[TBL] [Abstract][Full Text] [Related]
16. Association of the plasma xanthine oxidoreductase activity with the metabolic parameters and vascular complications in patients with type 2 diabetes.
Okuyama T; Shirakawa J; Nakamura T; Murase T; Miyashita D; Inoue R; Kyohara M; Togashi Y; Terauchi Y
Sci Rep; 2021 Feb; 11(1):3768. PubMed ID: 33580173
[TBL] [Abstract][Full Text] [Related]
17. A Newly Developed Method-Based Xanthine Oxidoreductase Activities in Various Human Liver Diseases.
Sato K; Naganuma A; Nagashima T; Arai Y; Mikami Y; Nakajima Y; Kanayama Y; Murakami T; Uehara S; Uehara D; Yamazaki Y; Murase T; Nakamura T; Uraoka T
Biomedicines; 2023 May; 11(5):. PubMed ID: 37239117
[TBL] [Abstract][Full Text] [Related]
18. Independent association of plasma xanthine oxidoreductase activity with hypertension in nondiabetic subjects not using medication.
Furuhashi M; Higashiura Y; Koyama M; Tanaka M; Murase T; Nakamura T; Akari S; Sakai A; Mori K; Ohnishi H; Saitoh S; Shimamoto K; Miura T
Hypertens Res; 2021 Sep; 44(9):1213-1220. PubMed ID: 34117403
[TBL] [Abstract][Full Text] [Related]
19. Possible role of insulin resistance in activation of plasma xanthine oxidoreductase in health check-up examinees.
Kurajoh M; Fukumoto S; Akari S; Murase T; Nakamura T; Takahashi K; Yoshida H; Nakatani S; Tsuda A; Morioka T; Mori K; Imanishi Y; Hirata K; Emoto M
Sci Rep; 2022 Jun; 12(1):10281. PubMed ID: 35717455
[TBL] [Abstract][Full Text] [Related]
20. Diurnal Variations in Serum Uric Acid, Xanthine, and Xanthine Oxidoreductase Activity in Male Patients with Coronary Artery Disease.
Shimizu M; Naito R; Sato A; Ishiwata S; Yatsu S; Shitara J; Matsumoto H; Murata A; Kato T; Suda S; Hiki M; Kuwabara M; Murase T; Nakamura T; Kasai T
Nutrients; 2023 Oct; 15(20):. PubMed ID: 37892555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]